<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30396969</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>11</Month>            <Day>13</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>13</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">1791-7530</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>38</Volume>                    <Issue>11</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Nov</Month>                    </PubDate>                </JournalIssue>                <Title>Anticancer research</Title>                <ISOAbbreviation>Anticancer Res.</ISOAbbreviation>            </Journal>            <ArticleTitle>Atypical Femoral Fractures (AFF) from Bone Remodeling Agents in Patients with Cancer.</ArticleTitle>            <Pagination>                <MedlinePgn>6439-6444</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.21873/anticanres.13005</ELocationID>            <Abstract>                <AbstractText>Anti-resorptive drugs like bisphosphonates (BP) and denosumab are widely used for prevention and treatment of skeletal diseases, such as osteoporosis and bone metastases and mainly work through the prevention of osteoclast-mediated bones resorption. BP can lead to atypical femoral fractures (AFF) that is a rare, easily misdiagnosed treatment-related complication with great impact on the quality of life of patients. We present a concise review of the literature on BP related AFF based on the cases of 3 breast cancer patients that reflect the diagnostic pitfall of this rare entity. In conclusion, breast cancer patients very often are exposed to BP use and are at risk of developing AFF.</AbstractText>                <CopyrightInformation>CopyrightÂ© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Kordoni</LastName>                    <ForeName>Maria</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>3rd Department of Oncology, Hygeia Hospital, Athens, Greece.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Rigakos</LastName>                    <ForeName>Georgios</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>3rd Department of Oncology, Hygeia Hospital, Athens, Greece grigakos@oncologists.gr.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kim</LastName>                    <ForeName>Young Hun Minjoo</ForeName>                    <Initials>YHM</Initials>                    <AffiliationInfo>                        <Affiliation>Neuroscience Department, John Hopkins University, Baltimore, MD, U.S.A.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kaklamanis</LastName>                    <ForeName>Loukas</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Onassis Cardiac Surgery Center, Athens, Greece.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Nikolatou-Galitis</LastName>                    <ForeName>Ourania</ForeName>                    <Initials>O</Initials>                    <AffiliationInfo>                        <Affiliation>School of Dentistry, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hadjiyassemi</LastName>                    <ForeName>Lina</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>3rd Department of Oncology, Hygeia Hospital, Athens, Greece.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Labropoulos</LastName>                    <ForeName>Stefanos</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>3rd Department of Oncology, Hygeia Hospital, Athens, Greece.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Razis</LastName>                    <ForeName>Evangelia</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>3rd Department of Oncology, Hygeia Hospital, Athens, Greece.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D002363">Case Reports</PublicationType>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>Greece</Country>            <MedlineTA>Anticancer Res</MedlineTA>            <NlmUniqueID>8102988</NlmUniqueID>            <ISSNLinking>0250-7005</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D050071">Bone Density Conservation Agents</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D004164">Diphosphonates</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>4EQZ6YO2HI</RegistryNumber>                <NameOfSubstance UI="D000069448">Denosumab</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D050071" MajorTopicYN="N">Bone Density Conservation Agents</DescriptorName>                <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000069448" MajorTopicYN="N">Denosumab</DescriptorName>                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D004164" MajorTopicYN="N">Diphosphonates</DescriptorName>                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005264" MajorTopicYN="N">Femoral Fractures</DescriptorName>                <QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName>                <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011859" MajorTopicYN="N">Radiography</DescriptorName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">AFF</Keyword>            <Keyword MajorTopicYN="N">antiresorptive</Keyword>            <Keyword MajorTopicYN="N">atypical femoral fracture</Keyword>            <Keyword MajorTopicYN="N">bisphosphonates</Keyword>            <Keyword MajorTopicYN="N">cancer</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>09</Month>                <Day>12</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>09</Month>                <Day>30</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>10</Month>                <Day>01</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>11</Month>                <Day>7</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>11</Month>                <Day>7</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>11</Month>                <Day>14</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30396969</ArticleId>            <ArticleId IdType="pii">38/11/6439</ArticleId>            <ArticleId IdType="doi">10.21873/anticanres.13005</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>